Company Overview and News
‘Thank God it’s Friday’ indeed has been the case for D-Street as traders carried on strong momentum all through the week on Friday as well. The Sensex, Nifty and Bank Nifty managed to end the week at record closing highs. In fact, it is the 21st time in 2018 that the index managed to clock this milestone, while the Nifty has achieved it for the 15th time.
BAJAJFINSV WESTLIFE 533292 532978 500570 505533 TATAMOTORS A2ZINFRA TTM
Ever wondered what happens to the golden oil used to cook your fries and nuggets once it’s no longer needed? Well, in India it’s being used as fuel. The master franchisee for McDonald’s restaurants in west and south India, Hardcastle Restaurants Pvt Ltd (HRPL), is using biodiesel from used cooking oil to power its fleet of delivery trucks in Mumbai. The biodiesel program began as a pilot last year.
Mumbai: The oil used to make your French fries are also powering the refrigerated delivery trucks and even the refrigeration equipment aboard the trucks of McDonald’s in Mumbai for the last nine months.
Podcast | An evening walk down Dalal Street: Sensex slips more than 100 points post US Fed outcome
500325 RELIANCE PUNJLLOYD HCTHY 533573 533155 TTNQY JUBLFOOD 533278 532215 JUBLINDS 532540 AXISBANK HSP RIGD JBLWY 532281 500477 CLNDY RLNIY ASHOKLEY PFZ AXB IBN 533320 PFIZER AKLD AXBKY AXBA APLLTD ICICIBANK WESTLIFE 532693 532174 HCLTECH TCS 505533 500680 PFE AKLS COALINDIA
Shares of Westlife Development advanced 2 percent intraday Thursday as brokerage Axis Capital has maintained buy call on the stock with a target of Rs 450 per share.
Mumbai: Hardcastle Restaurants Pvt. Ltd, the company that runs McDonald’s outlets in south and west India, is now serving food preservative-free patties for Indians who associate preservatives with unhealthy and processed foods.
Hardcastle Restaurants, the master franchisee of fast food chain McDonald's in west and south India, plans to invest Rs 800 crore to Rs 1,000 crore over the next three years to introduce healthier food options and digitise its stores.
3:30 pm Market at Close: After trading the day largely rangebound, intense buying in the last hour pushed up benchmark indices.
524558 TTQQY TCHQY 530239 533155 BHRQY TATACOMM 532755 JUBLFOOD 532215 SUVEN TATACHEM NEULANDLAB SYNDIBANK 532483 AXISBANK JMCPROJECT JBLWY 522263 HDFCBANK BHARTIARTL 500770 YESBANK UBNC AXB IBN DPUKY 532648 YYBKY TECHM CNRYY AXBKY 532454 AXBA ICICIBANK WESTLIFE 532276 HDB 532174 500180 505533 CANBK 500483 DPZ
Hardcastle Restaurants Pvt Ltd (HRPL), a master franchisee of McDonald’s restaurants in West and South India is planning to take its current 270 outlets to 400-500 outlets by 2022.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WESTLIFE JBLWY 533155 505533 JUBLFOOD
12h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
13h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
13h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...